Analyst Price Targets — EVAX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 9, 2026 12:42 pm | — | Lake Street | $9.00 | $3.08 | TheFly | Evaxion Biotech price target lowered to $9 from $11 at Lake Street |
| February 19, 2026 1:21 pm | — | Maxim Group | $10.00 | $3.25 | TheFly | Evaxion Biotech initiated with a Buy at Maxim |
| October 20, 2025 12:43 pm | Thomas Flaten | Lake Street | $11.00 | $7.14 | TheFly | Evaxion Biotech price target raised to $11 from $6 at Lake Street |
| September 25, 2025 3:18 pm | — | H.C. Wainwright | $16.00 | $4.53 | TheFly | Evaxion Biotech price target raised to $16 from $14 at H.C. Wainwright |
Latest News for EVAX
Evaxion A/S (EVAX) Q2 2026 Earnings Call Transcript
COPENHAGEN, Denmark, August 20, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, provides business update and announces second quarter 2026 financial results.
COPENHAGEN, Denmark, August 17, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, expands it pipeline of cancer vaccine programs with EVX-05 against the deadly brain cancer glioblastoma.
COPENHAGEN, Denmark, August 14, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will provide a business update and report its second quarter 2026 financial results on Thursday August 20, 2026, before opening of the Nasdaq CM.
COPENHAGEN, Denmark, July 17, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will present three-year clinical efficacy data from its phase 2 trial with personalized cancer vaccine candidate EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2026 to be held in Madrid, Spain, from October 23-27,…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EVAX.
U.S. House Trading
No House trades found for EVAX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.